14-95115670-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 0P and 0B.
This summary comes from the ClinGen Evidence Repository: The NM_177438.2:c.1904A>G variant in DICER1 is a missense variant predicted to cause substitution of Aspartic Acid by Serine at amino acid 635 (p.Asp635Ser). This variant received 0 phenotype points across 16 probands, including 3 unrelated females without tumors through age 50 (GTRs: 61756, 500031, PMID:33718253) (PS4 and BS2 are not met). The highest population minor allele frequency in gnomAD v2.1.1 (non-cancer) is 0.00003 (1/30526 alleles) in South Asian population (PM2_Supporting, BS1, and BA1 are not met). The computational predictor REVEL gives a score of 0.398, which is below the threshold of 0.5; however, the splice site predictors MaxEntScan and SpliceAI indicate creation of a new donor splice site (BP4 and PP3 not met). In summary, this variant meets the criteria to be classified as Uncertain Significance for DICER1 syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen DICER1 VCEP: No criteria. (Bayesian Points: 0; VCEP specifications version 1.1.0; 10/25/2022). LINK:https://erepo.genome.network/evrepo/ui/classification/CA7331374/MONDO:0017288/024
Frequency
Consequence
NM_177438.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DICER1 | NM_177438.3 | c.1904A>G | p.Asn635Ser | missense_variant | 11/27 | ENST00000343455.8 | NP_803187.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DICER1 | ENST00000343455.8 | c.1904A>G | p.Asn635Ser | missense_variant | 11/27 | 1 | NM_177438.3 | ENSP00000343745.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251466Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135914
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461860Hom.: 0 Cov.: 32 AF XY: 0.00000413 AC XY: 3AN XY: 727240
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
DICER1-related tumor predisposition Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 26, 2024 | This sequence change replaces asparagine, which is neutral and polar, with serine, which is neutral and polar, at codon 635 of the DICER1 protein (p.Asn635Ser). This variant is present in population databases (rs765551529, gnomAD 0.003%). This variant has not been reported in the literature in individuals affected with DICER1-related conditions. ClinVar contains an entry for this variant (Variation ID: 479636). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt DICER1 protein function with a positive predictive value of 80%. RNA analysis performed to evaluate the impact of this missense change on mRNA splicing indicates it does not significantly alter splicing (Invitae). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, reviewed by expert panel | curation | ClinGen DICER1 and miRNA-Processing Gene Variant Curation Expert Panel, ClinGen | Oct 25, 2022 | The NM_177438.2:c.1904A>G variant in DICER1 is a missense variant predicted to cause substitution of Aspartic Acid by Serine at amino acid 635 (p.Asp635Ser). This variant received 0 phenotype points across 16 probands, including 3 unrelated females without tumors through age 50 (GTRs: 61756, 500031, PMID: 33718253) (PS4 and BS2 are not met). The highest population minor allele frequency in gnomAD v2.1.1 (non-cancer) is 0.00003 (1/30526 alleles) in South Asian population (PM2_Supporting, BS1, and BA1 are not met). The computational predictor REVEL gives a score of 0.398, which is below the threshold of 0.5; however, the splice site predictors MaxEntScan and SpliceAI indicate creation of a new donor splice site (BP4 and PP3 not met). In summary, this variant meets the criteria to be classified as Uncertain Significance for DICER1 syndrome based on the ACMG/AMP criteria applied, as specified by the ClinGen DICER1 VCEP: No criteria. (Bayesian Points: 0; VCEP specifications version 1.1.0; 10/25/2022). - |
Hereditary cancer-predisposing syndrome Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Hereditary Cancer Group, L’Institut d'Investigació Biomèdica de Bellvitge | Dec 19, 2024 | PP3 - |
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2023 | The p.N635S variant (also known as c.1904A>G), located in coding exon 10 of the DICER1 gene, results from an A to G substitution at nucleotide position 1904. The asparagine at codon 635 is replaced by serine, an amino acid with highly similar properties. This alteration has been reported in the germline of an individual with reported papillary thyroid cancer from The Cancer Genome Atlas (TCGA) research network (Canberk S et al. Eur Thyroid J 2021 Feb;9(6):296-303). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at